Healthcare Realty Trust Incorporated (NYSE:HR) Receives Average Rating of "Hold" from Analysts

Key Points

• Healthcare Realty Trust has received an average rating of "Hold" from ten analysts, with two sell, five hold, and three buy recommendations.
• Analysts have adjusted price targets for the stock, with the average target being $18.75, while firm prices range from $16.00 to $23.00.
• The company recently cut its dividend, announcing a $0.24 per share payment, translating to an annual yield of 5.1%, with a substantial negative dividend payout ratio of -83.48%.

Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) has been given an average recommendation of "Hold" by the ten ratings firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $18.75.

Several analysts recently commented on HR shares. Wells Fargo & Company raised Healthcare Realty Trust from an "underweight" rating to an "equal weight" rating and raised their price objective for the stock from $16.00 to $18.00 in a research note on Monday. BTIG Research reissued a "buy" rating and issued a $20.00 price target on shares of Healthcare Realty Trust in a research note on Monday, September 29th. Weiss Ratings reissued a "sell (d+)" rating on shares of Healthcare Realty Trust in a research note on Wednesday, October 8th. Scotiabank raised Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and lifted their price target for the company from $18.00 to $20.00 in a research note on Friday, September 5th. Finally, Cantor Fitzgerald began coverage on Healthcare Realty Trust in a report on Wednesday, October 1st. They issued an "overweight" rating and a $23.00 price objective for the company.

Healthcare Realty Trust Stock Down 0.0%

HR stock opened at $18.68 on Friday. The business's fifty day moving average is $17.84 and its 200-day moving average is $16.32. The company has a market cap of $6.57 billion, a P/E ratio of -16.24 and a beta of 0.96. Healthcare Realty Trust has a twelve month low of $14.09 and a twelve month high of $18.97.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $287.07 million for the quarter, compared to the consensus estimate of $290.83 million. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%.During the same quarter in the prior year, the business posted $0.38 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. Research analysts anticipate that Healthcare Realty Trust will post 1.59 earnings per share for the current fiscal year.

Healthcare Realty Trust Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were issued a dividend of $0.24 per share. The ex-dividend date was Thursday, August 14th. This represents a $0.96 dividend on an annualized basis and a yield of 5.1%. Healthcare Realty Trust's dividend payout ratio (DPR) is presently -83.48%.

Insider Buying and Selling

In other news, EVP Julie F. Wilson sold 15,000 shares of the business's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $18.00, for a total transaction of $270,000.00. Following the completion of the sale, the executive vice president owned 113,419 shares in the company, valued at $2,041,542. The trade was a 11.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Thomas N. Bohjalian acquired 10,000 shares of Healthcare Realty Trust stock in a transaction dated Wednesday, August 13th. The shares were purchased at an average price of $16.46 per share, with a total value of $164,600.00. Following the acquisition, the director owned 75,520 shares of the company's stock, valued at approximately $1,243,059.20. This trade represents a 15.26% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.37% of the company's stock.

Institutional Investors Weigh In On Healthcare Realty Trust

A number of institutional investors have recently made changes to their positions in HR. Massachusetts Financial Services Co. MA bought a new stake in shares of Healthcare Realty Trust during the first quarter worth approximately $100,817,000. Norges Bank bought a new stake in shares of Healthcare Realty Trust in the second quarter valued at approximately $66,085,000. Centersquare Investment Management LLC bought a new stake in shares of Healthcare Realty Trust in the first quarter valued at approximately $30,834,000. Rush Island Management LP boosted its stake in shares of Healthcare Realty Trust by 13.8% in the second quarter. Rush Island Management LP now owns 14,260,152 shares of the real estate investment trust's stock valued at $226,166,000 after buying an additional 1,728,491 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Healthcare Realty Trust in the first quarter valued at approximately $22,285,000.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.